ResearcherAC Camargo HospitalActive in the last 2 years
Angelo Borsarelli Carvalho Brito
Matched on ORCID iD 0000-0001-9424-0010; OpenAlex author ID A5030264906, A5135224765. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer. Co-author DOI 10.21037/jgo-2025-1-1018↗
- Evolving survival patterns in pancreatic adenocarcinoma: a 23-year retrospective observational analysis. Co-author DOI 10.21037/jgo-2024-942↗
- A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas? Co-author DOI 10.1177/17588359241265213↗
- Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment… Co-author DOI 10.1177/10732748221149543↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Victor Hugo Fonseca de Jesus · 2 shared papers, 2023–2024 · strength 0.62
- Paper A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas? DOI 10.1177/17588359241265213↗
- Paper Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocar… DOI 10.1177/10732748221149543↗
- Felipe José Fernández Coimbra · 2 shared papers, 2025–2026 · strength 0.49
- Tiago Cordeiro Felismino · 2 shared papers, 2025–2026 · strength 0.49
- Arthur Conelian Gentili · 1 shared paper, 2024 · strength 0.31
- Mauro Daniel Spina Donadio · 1 shared paper, 2024 · strength 0.31
- Rachel P. Riechelmann · 1 shared paper, 2023 · strength 0.31
- Larissa Garcia · 1 shared paper, 2026 · strength 0.26
- Rodrigo Gomes Taboada · 1 shared paper, 2026 · strength 0.26
- María Paula Curado · 1 shared paper, 2025 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.